Boardroom Alpha
Boardroom Alpha
IPAR · Current Report (Form 8-K) · Filed February 24, 2026

Interparfums Inc — Current Report (Form 8-K)

Form
8-K
Filed
February 24, 2026
Period
Feb 24, 2026
Ticker
IPAR
Accession
0001753926-26-000347
Boardroom Alpha · Filing insights

Interparfums announces 2025 results and 2026 guidance; outlines launches, license extension, and tariff strategies.

About Interparfums Inc
Market cap
$3.6B
1Y TSR
+11.0%
3Y TSR
−3.0%
Board grade
B+
Sector
Consumer Defensive
CEO
Jean Madar
Last annual meeting: Sep 15, 2026 · View full Interparfums Inc profile →
ipar-20260224.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

 Date of Report (Date of Earliest Event Reported): February 24, 2026 

 
Interparfums, Inc.
(Exact name of Registrant as specified in its charter)

 

Delaware

 

0-16469

 

13-3275609

(State or other jurisdiction of
incorporation or organization)

 

Commission
File Number

 

(I.R.S. Employer
Identification No.)

 

551 Fifth Avenue, New York, NY 10176
(Address of Principal Executive Offices)

 

212.983.2640
(Registrant’s Telephone number, including area code)

 

   (Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2 below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting Material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

 

Trading Symbol(s)

 

Name of each exchange
on which registered

 

 

 

 

 

 Common Stock, $.001 par value per share

 

IPAR

 

The Nasdaq Stock Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.





Item 2.02 Results of Operations and Financial Conditions

 

  Certain portions of our press release dated February 24, 2026, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 2.02. They are as follows:


  • The 1st, 2nd (consisting of a table), 3rd through 6th full paragraphs relating to operational results for the four quarter of 2025 or full year ended December 31, 2025
  • Portion of 7th paragraph relating to operational results for the four quarter of 2025 or full year ended December 31, 2025
  • The 10th, 12th through 16th full paragraphs relating to results of operations
  • Part of the 11th paragraph relating to results of operations
  • The 17th paragraph relating to balance sheet information
  • The tables of unaudited consolidated statements of income and consolidated balance sheets

Item 7.01 Regulation FD Disclosure

 

  Certain portions of our press release dated February 24, 2026, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 7.01. They are as follows:


  • The last sentence in the 7th paragraph relating to Lacoste and Cavalli future launches
  • The 8th full paragraph relating future product launches for several brands, and the 15 year extension of the Guess license to help navigate the fragrance markets short-term volatility and deliver long-term results for the Company
  • The 9th full paragraph relating to future investments we are making towards product innovation that may allow the Company to see cautious optimism for 2026 and more favorable operating environment for 2027
  • Portion of the 11th paragraph relating to the future impact of tariffs on our business and the strategies and programs we are going to implement in 2026 to offset the possible effects
  • Paragraphs 18 through 19 relating to 2026 guidance
  • The 22nd through 25th paragraphs relating to the conference call to discuss the 2025 fourth quarter and 2025 full year results scheduled for February 25, 2026
  • The 28th paragraph relating to forward-looking information
  • The balance of such press release not otherwise incorporated by reference in Item 2.02 or 8.01

Item 8.01 Financial Statements and Exhibits.

  •  The 20th and 21st paragraphs relating to our cash dividend are incorporated by reference herein

Item 9.01 Financial Statements and Exhibits.


99.1 Our press release dated February 24, 2026






SIGNATURES

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused and authorized this report to be signed on its behalf by the undersigned.

 

Dated: February 24, 2026

 

 

Interparfums, Inc.

 

 

 

By:

/s/ Michel Atwood

 

 

Michel Atwood,

 

 

Chief Financial Officer




From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Interparfums Inc (IPAR)

Reference

Frequently asked questions

When did Interparfums Inc file this 8-K?
Interparfums Inc (IPAR) filed this Current Report (Form 8-K) with the SEC on February 24, 2026. The accession number assigned by EDGAR is 0001753926-26-000347.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Interparfums announces 2025 results and 2026 guidance; outlines launches, license extension, and tariff strategies. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Interparfums Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Interparfums Inc has filed under CIK 822663, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer